DescriptionRetina Base is a retinal diseases virtual library based on clinicalcases. This App, developed with Retina experts, will allow you tobrowse clinical cases in an intuitive way, going from a diseasetypical form to rarer forms.Thanks to a high performing keyword search engine, find the exactpicture you are looking for, and filter the results by Category(imaging technique, pathology, clinical sign, and author)Retina Base in an app in constant evolution: the contents andfunctionalities are regularly updated.The App is available in any circumstances on your tablet: onceinstalled and unlocked thanks to your ViaOpta login and password,(you can create a ViaOpta account at any time on www.viaopta.fr)you won’t need any internet connection to use the Retina BaseApp.In other words, Retina Base is:- A free tablet App with retina clinical cases based on multimodalimages- A clinical cases collection available at any time and evenwithout internet access- An app developed with ophthalmologists for ophthalmologists- A user-friendly interface for a unique experienceRetina Base clinical cases are also available on www.viaoopta.fr :ViaOpta website is an information platform with services dedicatedto ophthalmology healthcare professionals and generalaudience.Retina Base is downloadable from the App Store and reserved forHealthcare professionals.Retina Base App is an informative app aiming to illustratedifferent retinal diseases thanks to clinical cases.This App does not intend to give medical opinion or diagnosis anddoes not replace in any case a medical visit.This App is free and suggested by Novartis Pharma.

MAImoris-e est un journal personneld’auto-suivi des symptômes, dédié aux personnes atteintes d’uneMaladie Auto Inflammatoire (MAI), quelle que soit la Maladie AutoInflammatoire concernée. Cette application développée avec desexperts des maladies auto-inflammatoires vous permettra de saisirau plus près de leur apparition vos symptômes et l’ensemble desinformations qui s’y rapportent : dates de début et de fin,intensité, localisation ou encore facteurs déclenchants ...Si plusieurs membres de la famille sont touchés par une MaladieAuto Inflammatoire, chacun pourra disposer via son compte sécuriséde son propre journal de symptômes. Pour les enfants de moins de 11ans, un mode spécifique a été développé pour mieux s’adapter àcette tranche d'âge.Vous pourrez également consulter une carte de France des centresde référence et de compétences dans les Maladies AutoInflammatoires, saisir vos rendez-vous ou encore enregistrer lescoordonnées de votre médecin traitant. Vous aurez enfin lapossibilité d’envoyer par mail un récapitulatif de vos symptômes,pour ensuite l’imprimer et le transmettre si vous le souhaitez àvotre médecin, qui pourra ainsi suivre très précisément l’évolutionde vos symptômes.Cette application n’a pas vocation à donner un avis médical ouun diagnostic et ne se substitue en aucun cas à une consultationmédicale. Cette application est proposée gratuitement par NovartisPharma.MAImoris-e is a diary ofself-monitoring of symptoms, dedicated to people with AutoInflammatory Disease (MAI), regardless of the Auto InflammatoryDisease concerned. This application developed with expertsautoinflammatory diseases you will capture closer to emergingsymptoms and all information on them: start date, end date,intensity, location or triggers. ..If several family members are affected by Auto InflammatoryDisease, everyone can have via its secure account its own newspapersymptoms. For children under 11, a specific mode has been developedto better suit this age.You can also see a map of France with reference centers andskills in Auto Inflammatory Diseases, enter your appointments orrecord the coordinates of your doctor. You finally have theopportunity to send by email a summary of your symptoms, then printit and send it if you like your doctor, who can then closelymonitor the evolution of your symptoms.This application is not intended to provide medical advice ordiagnosis and not replace the need for a medical consultation. Thisapplication is available free by Novartis Pharma.

SymTrac™ HIVES - a free app that helps people with CSU tracksymptoms over time.

Die Jakavi® App: Informativ – übersichtlich -schnellDie JAKAVI®-App bietet Ihnen aktuelle Informationen rund um dasTherapiegebiet mit dem JAK1/JAK2 – Inhibitor: wichtige Fakten,Expertenstatements und neuste Studienergebnisse können jederzeitschnell und flexibel abgerufen werden.So hilft Ihnen diese App in der täglichen Praxis mit essentiellenInformationen zu Anwendung, Kontrolluntersuchungen,Wechselwirkungen und vielem mehr.Diese App ist nur für Fachkreise mit einem DocCheck® Loginbestimmt.The Jakavi® app:Informative - clear - quicklyThe JAKAVI®-app gives you the latest information about thetherapeutic area with the JAK1 / JAK2 - inhibitor: important facts,expert statements and latest study results can always be accessedquickly and flexibly.So this app will help you in daily practice with essentialinformation about application, check-ups, interactions, and muchmore.This app is intended for professionals with a DocCheck login.

The CSU Tracker allows you to trackyourChronic Spontaneous Urticaria on a daily basis. It is splitintothree main sections:SEVERITY TRACKERUse the Urticaria Activity Score (UAS) method of markinghowsevere your skin condition is along with adding notes and photossoyou can keep an accurate record. Angioedema (swelling) can alsobetracked whenever it presents.IMPACT TRACKERYou can also assess your quality of life, to reveal how muchCSUis affecting you. This can be recorded on a weekly basis.PROGRESS TRACKERThe Progress Tracker allows you to identify patterns inyourresults, and see how your CSU corresponds to your quality oflife.You can browse your history of daily UAS scores and even lookatyour UAS7 score (your daily scores, over 7 days). Photos andnotesare also available to view. With an export option, you cansendyour records to a healthcare professional, or to yourselfforfurther use.

The Novartis EyeLife app will be container appfor Lucentis immersive experiences. The app will be available inthe public app stores for HCPs. The app will provide 360 videoimmersive experiences for Living with DME, MCNV and RVO. Oncedownloaded, users can view the app in Flat or Cardboard View. Flatprovides a film experience that is best viewed in the user's hand,as per a normal video the user could watch on their smartphone.Cardboard view allows the user to insert their phone into acardboard viewer allowing a more immersive 360 experience, similarto that achieved with an Oculus headset.

SibA- Simulation bei Augenerkrankungen isteine speziell entwickelte App, welche die Symptome diverserKrankheitsbilder aufzeigt und durch die Kamerafunktion des iPads /iPhones widerspiegelt.Es ist ein Informationsteil integriert, welcher sowohl fürPatienten als auch für Angehörige die Symptome der Erkrankungenanschaulich darstellt.Es können Symptome zu- oder abgeschaltet werden und je nachSchweregrad die Einstellungen entsprechend angepasst werden.Enthalten sind die Altersbedingte Makula-Degeneration (AMD), dasDiabetische Makulaödem (DMÖ), die Retinalen Venenverschlüsse (RVV)und die pathologische Myopie (PM und mCNV).Die App soll nicht zu Diagnosenzwecken herangezogen werden, esist lediglich ein Information- und Aufklärungstool.Bei Fragen wenden Sie sich bitte an Ihren Augenarzt.Siba simulation of eyediseases is a specially designed app which shows the symptoms ofvarious diseases and reflects through the camera function of theiPad / iPhone.It is integrated into an information part, which for bothpatients and family members representing the symptoms of thedisease clearly.There may be symptoms are switched on or off and the settings areadjusted accordingly depending on the severity.Included are age-related macular degeneration (AMD), diabeticmacular edema, the edema (DME), the retinal vein occlusion (RVO)and pathological myopia (PM and mCNV).The app is not to be used for diagnostic purposes, it is only aninformation and education tool.For questions, please contact your eye doctor.

With GLICO 2 you do the daily log of your blood glucose.